Jorie Versmissen Selected Research

Albuminuria

11/2023	Cyclooxygenase-2 inhibition prevents renal toxicity but not hypertension during sunitinib treatment.
1/2022	Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage.
1/2020	Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jorie Versmissen Research Topics

Disease

22	Hypertension (High Blood Pressure) 01/2024 - 01/2015
10	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2018 - 04/2009
7	Neoplasms (Cancer) 10/2023 - 01/2019
7	Coronary Disease (Coronary Heart Disease) 01/2020 - 11/2008
6	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2019
4	Venous Thromboembolism 12/2023 - 01/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 01/2015
4	COVID-19 01/2021 - 01/2020
3	Albuminuria 11/2023 - 01/2020
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2019
3	Proteinuria 01/2023 - 01/2019
3	Atherosclerosis 05/2018 - 04/2010
3	Xanthomatosis (Xanthoma) 04/2010 - 09/2009
2	Thrombophilia 12/2023 - 01/2020
2	Thrombosis (Thrombus) 10/2023 - 07/2018
2	Stroke (Strokes) 11/2021 - 01/2015
2	Renal Insufficiency (Renal Failure) 01/2021 - 08/2015
2	Myocardial Infarction 01/2021 - 11/2008
2	Philadelphia Chromosome 12/2016 - 06/2016
2	Leukemia 12/2016 - 06/2016
1	Breast Neoplasms (Breast Cancer) 12/2023
1	Drug-Related Side Effects and Adverse Reactions 11/2022
1	Vascular Diseases (Vascular Disease) 11/2021
1	Disease Progression 01/2021
1	Orthostatic Hypotension (Postural Hypotension) 01/2021
1	Pulmonary Arterial Hypertension 03/2020
1	Hemorrhage 01/2020
1	Acute Coronary Syndrome 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Pulmonary Embolism 07/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2016

Drug/Important Bio-Agent (IBA)

11	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 01/2015
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 11/2008
6	CholesterolIBA 05/2018 - 04/2010
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2019
5	Endothelins (Endothelin)IBA 01/2022 - 01/2019
4	LDL Receptors (LDL Receptor)IBA 03/2015 - 12/2011
3	Angiogenesis InhibitorsIBA 11/2023 - 01/2020
3	DiureticsIBA 01/2023 - 01/2015
3	SaltsIBA 01/2023 - 01/2015
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2019
3	macitentanIBA 03/2020 - 01/2020
3	fibrin fragment D (D-dimer)IBA 01/2019 - 07/2018
2	Sunitinib (Sutent)FDA Link 11/2023 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2021
2	ProstaglandinsIBA 01/2022 - 08/2020
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022 - 01/2019
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2020
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2020
2	Endothelin Receptor AntagonistsIBA 03/2020 - 01/2019
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2010 - 04/2009
2	LDL CholesterolIBA 12/2009 - 04/2009
1	Tamoxifen FDA LinkGeneric 12/2023
1	4-hydroxy-N-desmethyltamoxifenIBA 12/2023
1	Celecoxib (Celebrex)FDA Link 11/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2023
1	AnticoagulantsIBA 10/2023
1	Dietary SodiumIBA 01/2023
1	SodiumIBA 01/2023
1	4- (benzyloxy)- 2,6- diamino- 5- nitropyrimidineIBA 01/2023
1	Endothelin-1 (Endothelin 1)IBA 01/2023
1	ReninIBA 01/2023
1	Methyldopa (Aldomet)FDA LinkGeneric 11/2022
1	Labetalol (Normodyne)FDA LinkGeneric 11/2022
1	Nifedipine (Adalat)FDA LinkGeneric 11/2022
1	CanrenoneIBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	Superoxides (Superoxide)IBA 01/2022
1	Perindopril FDA LinkGeneric 11/2021
1	perindopril drug combination indapamideIBA 11/2021
1	Gliclazide (Diamicron)IBA 11/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Dopamine beta-HydroxylaseIBA 01/2021
1	ambrisentan FDA Link 03/2020
1	AngiotensinsIBA 01/2020
1	TicagrelorIBA 01/2020
1	Prasugrel Hydrochloride FDA Link 01/2020
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2020
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2019
1	PCSK9 InhibitorsIBA 12/2018
1	Fibrinogen (Factor I)FDA Link 12/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2016
1	Imatinib Mesylate (Gleevec)FDA Link 12/2016
1	HDL CholesterolIBA 07/2016
1	LipidsIBA 11/2015
1	C-Reactive ProteinIBA 11/2015
1	Dalteparin (Dalteparin Sodium)FDA Link 08/2015
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2015
1	Tinzaparin (Innohep)FDA Link 08/2015
1	Atorvastatin (Lipitor)FDA Link 01/2015

Therapy/Procedure

10	Therapeutics 10/2023 - 12/2011
1	Deprescriptions 11/2022
1	Critical Care (Surgical Intensive Care) 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Percutaneous Coronary Intervention 01/2020
1	Hematopoietic Stem Cell Transplantation 06/2016
1	Drug Tapering 08/2015
1	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2015